Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual-action antihistamines/substance P antagonists from HMR

Aug. 12, 1999

Bayer will begin clinical trials of IL-4 antagonist for asthma

Aug. 12, 1999

Bayer reveals antiinflammatory PDE4 inhibitors in patent literature

Aug. 10, 1999

Medeva acquires additional European rights to ML Laboratories' MDPI device

Aug. 10, 1999

Novel PAF antagonist CPR-3005 claimed in patent literature by Clarion

Aug. 9, 1999

Novel cell adhesion inhibitors prepared by Rhone-Poulenc Rorer

Aug. 6, 1999

Discovery Laboratories begins phase II tyloxapol trial in cystic fibrosis

Aug. 6, 1999

Aeolus receives notice of allowance for U.S. patent covering synthetic SOD mimetics

Aug. 3, 1999

International patent recently published covering AstraZeneca PKC inhibitors

July 28, 1999

Heterocyclic compounds as potent and selective NK2 antagonists

July 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...